Blue Trust Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
228
-103
| -31% | -$54.1K | ﹤0.01% | 975 |
|
|
2025
Q1 | $210K | Buy |
331
+51
| +18% | +$32.3K | ﹤0.01% | 689 |
|
|
2024
Q4 | $199K | Sell |
280
-238
| -46% | -$170K | ﹤0.01% | 662 |
|
|
2024
Q3 | $544K | Buy |
518
+235
| +83% | +$247K | 0.01% | 432 |
|
|
2024
Q2 | $272K | Buy |
283
+215
| +316% | +$207K | ﹤0.01% | 590 |
|
|
2024
Q1 | $65.4K | Sell |
68
-74
| -52% | -$71.2K | ﹤0.01% | 834 |
|
|
2023
Q4 | $116K | Buy |
142
+66
| +87% | +$53.9K | ﹤0.01% | 625 |
|
|
2023
Q3 | $55K | Buy |
76
+12
| +19% | +$8.68K | ﹤0.01% | 817 |
|
|
2023
Q2 | $53K | Sell |
64
-174
| -73% | -$144K | ﹤0.01% | 678 |
|
|
2023
Q1 | $172K | Buy |
238
+40
| +20% | +$28.9K | ﹤0.01% | 590 |
|
|
2022
Q4 | $137K | Buy |
198
+149
| +304% | +$103K | ﹤0.01% | 568 |
|
|
2022
Q3 | $29K | Buy |
49
+30
| +158% | +$17.8K | ﹤0.01% | 942 |
|
|
2022
Q2 | $13K | Buy |
+19
| New | +$13K | ﹤0.01% | 1118 |
|